Infection with HIV is a major risk factor for the development of resistance to key second-line anti-tuberculosis (TB) drugs, US investigators report in the online edition of Clinical Infectious Diseases. “The present study provides the first comprehensive assessment of predictors of acquired resistance to two key classes of second-line antituberculosis drugs, fluoroquinolones and second-line …
